Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,095 public trials 2,042 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Completed

Safety Study of NHL With 90Y-hLL2 IgG

NCT00421395

Conditions
B-cell NHL, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Research Unit 463 INSERM Nantes, Cedex, France
  • Service des Maladies du Sang Lille, France
  • University Hospital Dresden Dresden, Germany
  • Klinikum der Georg-August-Universitat Gottingen Göttingen, Germany
View Trial Details
Completed

A Study to Assess Renal Function Response to Treatment in Patients With Relapsed Multiple Myeloma and Creatinine Clearance

NCT02849444

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Hospital Torrecárdenas Almería, Andalusia, Spain
  • Hospital Universitario Puerta del Mar Cadiz, Andalusia, Spain
  • Hospital Virgen de la Nieves Granada, Andalusia, Spain
  • Hospital Universitario Ciudad de Jaen Jaén, Andalusia, Spain
View all 40 locations
View Trial Details
Completed

Phase I/II Study of hLL1 in Multiple Myeloma

NCT00421525

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations
  • Winship Cancer Institute, Emory University Atlanta, Georgia, United States
  • Center for Cancer Care Goshen, Indiana, United States
  • Hackensack University Medical Center Hackensack, New Jersey, United States
  • Roswell Park Cancer Institute Buffalo, New York, United States
View Trial Details
Completed

Ph I/II Study of Subcutaneously Administered Veltuzumab (hA20) in NHL and CLL

NCT00546793

Conditions
CLL, Chronic Disease, Dendritic Cell Sarcoma, Interdigitating, +35 more
Locations
  • Lewis Cancer Center and Research Pavilion Savannah, Georgia, United States
  • Cancer Care at Saint Clare's/Saint Clares Hospital Oncology & Hematology Specialists, P.A. Denville, New Jersey, United States
  • Morristown Memorial Hospital Morristown, New Jersey, United States
  • New York Hospital Weill Cornell Medical Center New York, United States
View Trial Details
Completed

Efficacy and Safety Study of Tenalisib (RP6530), a Novel PI3K δ/γ Dual Inhibitor in Patients With Relapsed/Refractory Indolent Non-Hodgkin's Lymphoma (iNHL)

NCT03711578

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • Clearview Cancer Institute Huntsville, Alabama, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • Florida cancer specialists & Research Institute Florida City, Florida, United States
  • Florida Cancer Specialist/ South Fort Myers, Florida, United States
View Trial Details
Completed

Glutamine PET Imaging in LAM

NCT04388371

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
Locations
  • Vanderbilt University Medical Center Nashville, Tennessee, United States
View Trial Details
Completed

Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients With Cancer

NCT00369564

Conditions
Burkitt Lymphoma, Chemically-Induced Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +46 more
Locations
  • Lee Cancer Care of Lee Memorial Health System Fort Myers, Florida, United States
  • Butterworth Hospital at Spectrum Health Grand Rapids, Michigan, United States
  • Children's Hospitals and Clinics of Minnesota - Minneapolis Minneapolis, Minnesota, United States
  • Hackensack University Medical Center Cancer Center Hackensack, New Jersey, United States
View Trial Details

Related conditions